flavobacterium heparinum
Recently Published Documents


TOTAL DOCUMENTS

64
(FIVE YEARS 2)

H-INDEX

22
(FIVE YEARS 0)

Glycobiology ◽  
2021 ◽  
Author(s):  
Jiandong Wu ◽  
Pradeep Chopra ◽  
Geert-Jan Boons ◽  
Joseph Zaia

Abstract A library of 23 synthetic heparan sulfate (HS) oligosaccharides, varying in chain length, types, and positions of modifications, was used to analyze the substrate specificities of heparin lyase III enzymes from both Flavobacterium heparinum and Bacteroides eggerthii. The influence of specific modifications, including N-substitution, 2-O sulfation, 6-O sulfation, and 3-O sulfation on lyase III digestion was examined systematically. It was demonstrated that lyase III from both sources can completely digest oligosaccharides lacking O-sulfates. 2-O Sulfation completely blocked cleavage at the corresponding site; 6-O and 3-O sulfation on glucosamine residues inhibited enzyme activity. We also observed that there are differences in substrate specificities between the two lyase III enzymes for highly sulfated oligosaccharides. These findings will facilitate obtaining and analyzing the functional sulfated domains from large HS polymer, to better understand their structure/function relationships in biological processes.


2020 ◽  
Author(s):  
A.N. Kalinina ◽  
L.N. Borschevskaya ◽  
T.L. Gordeeva ◽  
E. Patrusheva ◽  
S.P. Sineokiy

AbstractThe cleavage of heparin by heparin lyases showed great potential as a cost-effective and innoxious method for producing heparin with low molecular weight (LMWH). One of the most studied and sought heparin lyase is heparinase I (HepI). However, the industrial use of HepI was largely hampered by its low specific activity and thermal stability. In this article we describe increasing in specific heparinase I activity by stepwise site-directed mutagenesis. Thus after two cycles of mutagenesis, we obtained mutant heparinase I Flavobacterium heparinum with significantly increased specific activity (25%).


2006 ◽  
Vol 843 (2) ◽  
pp. 209-215 ◽  
Author(s):  
X MA ◽  
Z WANG ◽  
S LI ◽  
Q SHEN ◽  
Q YUAN

2003 ◽  
Vol 37 (2) ◽  
pp. 115 ◽  
Author(s):  
Jair A. K. Aguiar ◽  
Cilene R. Lima ◽  
Alessandra G. A. Berto ◽  
Yara M. Michelacci

2003 ◽  
Author(s):  
Charles Thomas Parker ◽  
Nicole Danielle Osier ◽  
George M Garrity ◽  
Dorothea Taylor

2002 ◽  
Vol 184 (12) ◽  
pp. 3242-3252 ◽  
Author(s):  
Françoise Blain ◽  
A. Lydia Tkalec ◽  
Zhongqi Shao ◽  
Catherine Poulin ◽  
Marc Pedneault ◽  
...  

ABSTRACT A system for high-level expression of heparinase I, heparinase II, heparinase III, chondroitinase AC, and chondroitinase B in Flavobacterium heparinum is described. hepA, along with its regulatory region, as well as hepB, hepC, cslA, and cslB, cloned downstream of the hepA regulatory region, was integrated in the chromosome to yield stable transconjugant strains. The level of heparinase I and II expression from the transconjugant strains was approximately fivefold higher, while heparinase III expression was 10-fold higher than in wild-type F. heparinum grown in heparin-only medium. The chondroitinase AC and B transconjugant strains, grown in heparin-only medium, yielded 20- and 13-fold increases, respectively, in chondroitinase AC and B expression, compared to wild-type F. heparinum grown in chondroitin sulfate A-only medium. The hepA upstream region was also studied using cslA as a reporter gene, and the transcriptional start site was determined to be 26 bp upstream of the start codon in the chondroitinase AC transconjugant strain. The transcriptional start sites were determined for hepA in both the wild-type F. heparinum and heparinase I transconjugant strains and were shown to be the same as in the chondroitinase AC transconjugant strain. The five GAG lyases were purified from these transconjugant strains and shown to be identical to their wild-type counterparts.


Author(s):  
Ishan Capila ◽  
Yi Wu ◽  
David W Rethwisch ◽  
Allan Matte ◽  
Miroslaw Cygler ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document